Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 2 January 2027
- Last conf. stmt
- 19 December 2025
Petalion Therapeutics Limited
- Incorporated
- 20 December 2023 (2 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Cheryl Ann MaleyDavid John Mcintyre
- Accounts type
- Small
- Region
- East of England
- Address
- Cambridge PartnershipDorothy Hodgkin Building Babraham Research CampusBabrahamCambridgeCB22 3FH
Officers 4 active
Officer details are public data from the Companies House register.
Maley, Cheryl Ann
Director · Appointed 19 October 2026
Australian
Born May 1968 (58)
Corporate Secretary · Appointed 6 April 2024
Mcintyre, David John
Director · Appointed 6 April 2024
American
Born October 1970 (56)
British
Born January 1990 (36)
Officer history (2 former)
19 October 2026
Appointed Maley, Cheryl Ann as Director
19 October 2026
Resigned Shahidi, Mehdi as Director
6 April 2024
6 April 2024
Appointed Mcintyre, David John as Director
6 April 2024
Appointed Shahidi, Mehdi as Director
6 April 2024
20 December 2023
20 December 2023
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 November 2026 | Statement of capital following an allotment of shares | |||
| 9 November 2026 | Memorandum and Articles of Association | |||
| 9 November 2026 | Resolutions | — | ||
| 22 October 2026 | Termination of appointment of a director | |||
| 22 October 2026 | Appointment of a director |
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →